Estradiol 2mg tablets

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Estradiol

Available from:

ReSource Medical UK Ltd

ATC code:

G03CA03

INN (International Name):

Estradiol

Dosage:

2mg

Pharmaceutical form:

Oral tablet

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 06040101

Patient Information leaflet

- acne
- muscle cramps
- vaginal discharge
- feeling tired
- swelling of the breasts
- change in sex drive
VERY RARE (IN LESS THAN 1 IN 10,000 PATIENTS TREATED, NOT KNOWN
(CANNOT
BE ESTIMATED FROM THE AVAILABLE DATA)):
- reduction in red blood cells which can make the skin pale and cause
weakness or breathlessness (anaemia)
If unscheduled bleeding occurs after some time on HRT, you should
contact
your doctor. If unscheduled bleeding continues after stopping HRT, it
may be
necessary to perform tests to exclude disease of the endometrium
(the lining of the uterus).
Changes can occur in the levels of certain proteins and hormones in
the
blood. The action of the hormones in the body is not affected. You
should tell
your doctor that you are taking HRT if you are to have a blood test.
The following side effects have been reported in association with
estradiol
treatment (frequency unknown):
• fibroids get bigger (growth in the womb increase)
• chorea (muscle twitches)
• worsening of fits (epilepsy)
• blood clots in the arteries (arterial thromboembolism)
• inflammation of the pancreas (pancreatitis) in women with
pre-existing high
levels of certain blood fats (hypertriglyceridemia)
• a condition where gastric juices, containing acid, travel back
from the
stomach into the oesophagus (gastroesophageal reflux disease) symptoms
include heartburn
• liver disorders, which may include jaundice (yellowing of the
skin)
• discolouration of the skin especially of the face or neck known as
‘’pregnancy patches’’ (chloasma)
• rash with target shaped reddening or sores (erythema multiforme)
• skin discolouration (purpura)
• swelling of the skin around face and throat (angioedema)
• urinary incontinence
• painful/lumpy breasts (fibrocystic breast disease)
REPORTING OF SIDE EFFECTS
If you get any side effects, talk to your doctor, pharmacist or nurse.
This
includes any possible side effects not listed in this leaflet. You can
also report
side effects directly via the Yellow Card Scheme at: www.mhra.gov.